Related Experiment Video

Updated: Jun 30, 2025

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

364

Protein tyrosine phosphatase 1B in metabolic diseases and drug development

Mirela Delibegović1, Sergio Dall'Angelo2, Ruta Dekeryte2

  • 1Aberdeen Cardiovascular and Diabetes Centre, University of Aberdeen, Institute of Medical Sciences, Aberdeen, UK. m.delibegovic@abdn.ac.uk.

Nature Reviews. Endocrinology
|March 23, 2024
PubMed

Insights

Protein tyrosine phosphatase 1B (PTP1B) is a key regulator of metabolic pathways and a therapeutic target for diabetes, obesity, and cancer. Inhibitor development and clinical trials show promise for treating these conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Protein tyrosine phosphatase 1B (PTP1B) is a non-transmembrane enzyme regulating critical signaling pathways.
  • PTP1B negatively regulates insulin and leptin signaling, implicating it in cardiometabolic diseases and cancers.

Purpose of the Study:

  • To review the cellular roles and regulation of PTP1B.
  • To discuss PTP1B's association with various disorders based on preclinical and human studies.
  • To summarize PTP1B inhibitor development, clinical trial outcomes, and future therapeutic directions.

Main Methods:

  • Literature review of PTP1B's function, regulation, and disease association.
  • Analysis of preclinical in vivo and human study data.
  • Summary of PTP1B inhibitor development and clinical trial results.

Main Results:

  • PTP1B is a validated therapeutic target for type 2 diabetes, obesity, and metastatic breast cancer.
  • Several PTP1B inhibitors have advanced to clinical trials.
  • Challenges in targeting PTP1B are being addressed, with ongoing development of inhibitors.

Conclusions:

  • PTP1B plays a significant role in metabolic regulation and disease pathogenesis.
  • PTP1B inhibitors represent a promising therapeutic strategy for multiple diseases.
  • Future research focuses on optimizing PTP1B inhibition and exploring dual phosphatase inhibitors.

More Related Videos

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K
A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.4K

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K